T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas
Authors
Politi, Letterio S.Brugnara, G.
Castellano, A.
Cadioli, M.
Altabella, L.
Peviani, M.
Mazzoleni, S.
Falini, A.
Galli, R.
UMass Chan Affiliations
Department of RadiologyDocument Type
Response or CommentPublication Date
2016-06-01
Metadata
Show full item recordAbstract
We read with great interest the article by Arevalo-Perez et al, describing the potential value of T1-weighted dynamic contrast-enhanced MR imaging (DCE-MR imaging) as a biomarker for epidermal growth factor receptor variant III (EGFRvIII) mutation in patients with glioblastoma (GBM).Source
AJNR Am J Neuroradiol. 2016 Jun;37(6):E49-51. Mar 17. Link to article on publisher's siteDOI
10.3174/ajnr.A4774Permanent Link to this Item
http://hdl.handle.net/20.500.14038/48122PubMed ID
26988813Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.3174/ajnr.A4774